After hours: October 17 at 7:51 PM EDT Loading Chart for ATRA ...

Atara Biotherapeutics, Inc. (NASDAQ:ATRA), a biopharmaceutical company, announced the appointment of Eric Hyllengren as the new Chief Operating Officer (COO) on Monday. Hyllengren will retain his ...

Atara Biotherapeutics (ATRA) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings ...

Cox Internet services allow you to sign up online in minutes and include a 30-day money-back guarantee. Cox offers multiple internet plans with prices starting at $39.99 a month. Cox’s internet ...

Atara Biotherapeutics' cell therapy Ebvallo should be approved to treat Epstein-Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD), according to the EMA's human medicines ...

Atara Biotherapeutics, Inc. (NASDAQ:ATRA), a biopharmaceutical company, announced the appointment of Eric Hyllengren as the new Chief Operating Officer (COO) on Monday. Hyllengren will retain his ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to ...

Atara Biotherapeutics (ATRA) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings ...